Literature DB >> 33720897

Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes.

Jonathan Graff-Radford1, Timothy G Lesnick2, Michelle M Mielke1,2, Eleni Constantopoulos3, Alejandro A Rabinstein1, Scott A Przybelski2, Prashanthi Vemuri4, Hugo Botha1, David T Jones1, Vijay K Ramanan1, Ronald C Petersen1, David S Knopman1, Bradley F Boeve1, Melissa E Murray5, Dennis W Dickson5, Clifford R Jack4, Kejal Kantarci4, R Ross Reichard3.   

Abstract

BACKGROUND: The relationship between cerebral microbleeds (CMBs) on hemosiderin-sensitive MRI sequences and cerebral amyloid angiopathy (CAA) remains unclear in population-based participants or in individuals with dementia.
OBJECTIVE: To determine whether CMBs on antemortem MRI correlate with CAA.
METHODS: We reviewed 54 consecutive participants with antemortem T2*GRE-MRI sequences and subsequent autopsy. CMBs were quantified on MRIs closest to death. Autopsy CAA burden was quantified in each region including leptomeningeal/cortical and capillary CAA. By a clustering approach, we examined the relationship among CAA variables and performed principal component analysis (PCA) for dimension reduction to produce two scores from these 15 interrelated predictors. Hurdle models assessed relationships between principal components and lobar CMBs.
RESULTS: MRI-based CMBs appeared in 20/54 (37%). 10 participants had ≥2 lobar-only CMBs. The first two components of the PCA analysis of the CAA variables explained 74% variability. The first rotated component (RPC1) consisted of leptomeningeal and cortical CAA and the second rotated component of capillary CAA (RPC2). Both the leptomeningeal and cortical component and the capillary component correlated with lobar-only CMBs. The capillary CAA component outperformed the leptomeningeal and cortical CAA component in predicting lobar CMBs. Both capillary and the leptomeningeal/cortical components correlated with number of lobar CMBs.
CONCLUSION: Capillary and leptomeningeal/cortical scores correlated with lobar CMBs on MRI but lobar CMBs were more closely associated with the capillary component. The capillary component correlated with APOEɛ4, highlighting lobar CMBs as one aspect of CAA phenotypic diversity. More CMBs also increase the probability of underlying CAA.

Entities:  

Keywords:  Alzheimer’s disease; capillaries; cerebral amyloid angiopathy; neuropathology

Year:  2021        PMID: 33720897      PMCID: PMC8113155          DOI: 10.3233/JAD-201536

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  29 in total

1.  Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage.

Authors:  Sergi Martinez-Ramirez; Jose-Rafael Romero; Ashkan Shoamanesh; Ann C McKee; Ellis Van Etten; Octavio Pontes-Neto; Eric A Macklin; Alison Ayres; Eitan Auriel; Jayandra J Himali; Alexa S Beiser; Charles DeCarli; Thor D Stein; Victor E Alvarez; Matthew P Frosch; Jonathan Rosand; Steven M Greenberg; M Edip Gurol; Sudha Seshadri; Anand Viswanathan
Journal:  Alzheimers Dement       Date:  2015-06-13       Impact factor: 21.566

2.  Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions.

Authors:  Jonathan Graff-Radford; Jeremiah A Aakre; David S Knopman; Christopher G Schwarz; Kelly D Flemming; Alejandro A Rabinstein; Jeffrey L Gunter; Chadwick P Ward; Samantha M Zuk; A J Spychalla; Gregory M Preboske; Ronald C Petersen; Kejal Kantarci; John Huston; Clifford R Jack; Michelle M Mielke; Prashanthi Vemuri
Journal:  Mayo Clin Proc       Date:  2020-06       Impact factor: 7.616

Review 3.  Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.

Authors:  Steven M Greenberg; Andreas Charidimou
Journal:  Stroke       Date:  2018-01-15       Impact factor: 7.914

4.  Two types of sporadic cerebral amyloid angiopathy.

Authors:  Dietmar Rudolf Thal; Estifanos Ghebremedhin; Udo Rüb; Haruyasu Yamaguchi; Kelly Del Tredici; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

5.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.

Authors:  Matthew Schrag; Grant McAuley; Justine Pomakian; Arshad Jiffry; Spencer Tung; Claudius Mueller; Harry V Vinters; E Mark Haacke; Barbara Holshouser; Daniel Kido; Wolff M Kirsch
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088

6.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.

Authors:  F Fazekas; R Kleinert; G Roob; G Kleinert; P Kapeller; R Schmidt; H P Hartung
Journal:  AJNR Am J Neuroradiol       Date:  1999-04       Impact factor: 3.825

7.  Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

8.  Incidence of symptomatic hemorrhage in patients with lobar microbleeds.

Authors:  Ellis S van Etten; Eitan Auriel; Kellen E Haley; Alison M Ayres; Anastasia Vashkevich; Kristin M Schwab; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol
Journal:  Stroke       Date:  2014-06-19       Impact factor: 7.914

9.  Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies.

Authors:  Prashanthi Vemuri; Jeffrey L Gunter; Matthew L Senjem; Jennifer L Whitwell; Kejal Kantarci; David S Knopman; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2007-10-22       Impact factor: 6.556

10.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

View more
  3 in total

1.  Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee.

Authors:  Gregory S Day; Nikolaos Scarmeas; Richard Dubinsky; Katherine Coerver; Anitra Mostacero; Brooks West; Scott R Wessels; Melissa J Armstrong
Journal:  Neurology       Date:  2022-02-23       Impact factor: 11.800

2.  Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.

Authors:  Stuart J McCarter; Timothy G Lesnick; Val J Lowe; Alejandro A Rabinstein; Scott A Przybelski; Alicia Algeciras-Schimnich; Vijay K Ramanan; Clifford R Jack; Ronald C Petersen; David S Knopman; Bradley F Boeve; Kejal Kantarci; Prashanthi Vemuri; Michelle M Mielke; Jonathan Graff-Radford
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal.

Authors:  Stuart J McCarter; Timothy G Lesnick; Val Lowe; Michelle M Mielke; Eleni Constantopoulos; Alejandro A Rabinstein; Scott A Przybelski; Hugo Botha; David T Jones; Vijay K Ramanan; Clifford R Jack; Ronald C Petersen; David Knopman; Bradley F Boeve; Melissa E Murray; Dennis W Dickson; Prashanthi Vemuri; Kejal Kantarci; R Ross Reichard; Jonathan Graff-Radford
Journal:  Neurology       Date:  2021-09-09       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.